乌鸦传媒

A look at the feasibility of coronary angiography and angioplasty procedures using the . (European Heart Journal)

FDA approved , a radiotracer for positron emission tomography myocardial perfusion imaging indicated for evaluation of myocardial ischemia and infarction in adults with known or suspected coronary artery disease.

The agency also gave clearance to the that facilitates valve-in-valve transcatheter aortic valve replacement in people at risk of coronary obstruction, Pi-Cardia announced.

Based on the BioImage study, people with had an increased risk of death over a decade later, regardless of traditional cardiovascular risk factors. (Journal of the American College of Cardiology)

For coronary stenting in people with high bleeding risk, the ultrathin-strut biodegradable-polymer sirolimus-eluting met noninferiority criteria in a randomized trial. (Circulation: Cardiovascular Interventions)

Sprinkling across densely populated areas may help with faster ECG access and percutaneous coronary intervention in low- and middle-income countries. (Lancet Regional Health-Southeast Asia)

How did a cardiologist in August? (Space.com)

The Heart Rhythm Society put out a statement stressing that physicians who perform atrial fibrillation ablation must in electrophysiology-based testing and mapping and advanced ablation therapeutics. (Heart Rhythm)

Clinical practice was affected by guideline-directed medical therapies after ischemic stroke. (Stroke)

was a risk factor for sudden cardiac death in young people with hypertrophic cardiomyopathy. (JAMA Cardiology)

Current driving restrictions may not be in line with real-world after implantable cardioverter-defibrillator (ICD) implantation. (Heart)

Cereno Scientific announced that the investigational had promising phase IIa results in pulmonary arterial hypertension.

One observational analysis supports brief intermittent bursts of to offset cardiovascular risks from a sedentary lifestyle. (European Journal of Preventive Cardiology)

In the PANORAMA-HF trial, was arguably no better than enalapril for treating pediatric patients with heart failure attributable to systemic left ventricular systolic dysfunction. (Circulation)

was frequently discontinued due to safety concerns in a randomized trial of patients with moderate stage chronic kidney disease. (Nature Medicine)

Differences in heart failure risks are arguably more pronounced than those between Black and white patients. (JAMA Network Open)

Getting heart transplant care at high-quality hospitals did not mitigate the excess risk of postoperative complications for , suggesting contributions from persistent neighborhood deprivation. (Journal of Heart and Lung Transplantation)

Comment